Influence of blood group and von Willebrand factor on population pharmacokinetics and dose individualization of recombinant factor VIII in Taiwanese patients with haemophilia A.
Haemophilia
; 28(2): 230-238, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-35060242
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Von Willebrand Diseases
/
Blood Group Antigens
/
Hemophilia A
Type of study:
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Haemophilia
Journal subject:
HEMATOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Tailandia